Source: Annual Congress 2011 - COPD mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Ling, Y. Lin (Nanjing, China). The study of proton magnetic resonance spectroscopy on hippocampus in rats with chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 3584

Member's Comments

No comment yet.

Related content which might interest you: Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study Source: Eur Respir J 2004; 24: 980-986 Year: 2004 Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Oxygen-enhanced MRI of the lung in the assessment of chronic obstructive pulmonary disease Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Acute changes to sildenafil in pulmonary arterial hypertension assessed by magnetic resonance imaging Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI) Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension Source: Eur Respir Rev, 29 (156) 190138; 10.1183/16000617.0138-2019 Year: 2020 Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial Source: Eur Respir J 2009; 34: 1311-1321 Year: 2009 Cardiac magnetic resonance imaging in pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 526-534 Year: 2013 Magnetic resonance to assess disease severity and response to therapy in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension Source: Eur Respir J 2009; 33: 1454-1466 Year: 2009 Restricted magnetic resonance diffusion of lung consolidation is not specific for respiratory exacerbation Source: Eur Respir J, 50 (5) 1701621; 10.1183/13993003.01621-2017 Year: 2017 Obstructive sleep apnoea severity and liver steatosis measured by magnetic resonance imaging Source: Eur Respir J, 55 (1) 1901514; 10.1183/13993003.01514-2019 Year: 2020 Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017 Year: 2017 Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019 Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting? Source: Eur Respir Rev, 29 (156) 200139; 10.1183/16000617.0139-2020 Year: 2020 Computed tomography and magnetic resonance imaging: past, present and future Source: Eur Respir J 2002; 19: 3S-12S Year: 2002 Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations Source: Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017 Year: 2017 Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016 Year: 2017